Specific transfer of oncolytic adenoviruses by mesenchymal stem cells for the elimination of pancreatic tumour stem cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase

  2014cited by this paper
• Cancer Immunology at the Crossroads : Experimental Immunotherapies Oncolytic Viruses and Their Application to Cancer Immunotherapy

  2014cited by this paper
• The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells

  2014cited by this paper
• Optimum chemotherapy in the management of metastatic pancreatic cancer.

  2014cited by this paper
• Oncolytic viral therapy: targeting cancer stem cells

  2014cited by this paper
• The chick embryo as an expanding experimental model for cancer and cardiovascular research

  2014cited by this paper
• Systematic review of novel ablative methods in locally advanced pancreatic cancer.

  2014cited by this paper
• Adenovirus signalling in entry

  2013cited by this paper
• Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment.

  2013cited by this paper
• The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.

  2013cited by this paper
• Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer

  2013influential reference
• Viral therapy for pancreatic cancer: tackle the bad guys with poison.

  2013cited by this paper
• TRAIL on trial: preclinical advances in cancer therapy.

  2013cited by this paper
• New viruses for cancer therapy: meeting clinical needs

  2013cited by this paper
• Tumor microenvironment: bone marrow-mesenchymal stem cells as key players.

  2013cited by this paper
• Oncolytic virus therapy for cancer: the first wave of translational clinical trials.

  2013cited by this paper
• Molecular evolution of human adenoviruses

  2013cited by this paper
• Mesenchymal stem cells regulate epithelial–mesenchymal transition and tumor progression of pancreatic cancer cells

  2013cited by this paper
• Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy.

  2013cited by this paper
• Therapeutic advances in pancreatic cancer.

  2013cited by this paper
• The Repression Domain of the E1B 55-Kilodalton Protein Participates in Countering Interferon-Induced Inhibition of Adenovirus Replication

  2013cited by this paper
• Presence of the Coxsackievirus and Adenovirus Receptor (CAR) in human neoplasms: a multitumour array analysis

  2013cited by this paper
• Predictive Modeling of In Vivo Response to Gemcitabine in Pancreatic Cancer

  2013cited by this paper
• First-Line Treatment for Advanced Pancreatic Cancer Highlights from the “ 2013 ASCO Gastrointestinal Cancers Symposium ”

  2013cited by this paper
• Mesenchymal stem cell transformation and sarcoma genesis

  2013cited by this paper
• Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine

  2013cited by this paper
• Oncolytic viruses as therapeutic cancer vaccines

  2013cited by this paper
• Reversing the Intractable Nature of Pancreatic Cancer by Selectively Targeting ALDH-High, Therapy-Resistant Cancer Cells

  2013cited by this paper
• Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.

  2013cited by this paper
• Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas

  2013cited by this paper
• Adenovirus E1B 19-Kilodalton Protein Modulates Innate Immunity through Apoptotic Mimicry

  2013cited by this paper
• Adenovirus E1A Oncogene Induces Rereplication of Cellular DNA and Alters DNA Replication Dynamics

  2013cited by this paper
• Heterogeneity and Targeting of Pancreatic Cancer Stem Cells

  2012cited by this paper
• Effective combination therapy for malignant glioma with TRAIL-secreting mesenchymal stem cells and lipoxygenase inhibitor MK886.

  2012cited by this paper
• A Fiber Chimeric CRAd Vector Ad5/11-D24 Double-Armed with TRAIL and Arresten for Enhanced Glioblastoma Therapy

  2012cited by this paper
• Anti-Fab aptamers for shielding virus from neutralizing antibodies.

  2012cited by this paper
• The Implications of Cancer Stem Cells for Cancer Therapy

  2012cited by this paper
• A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity

  2012cited by this paper
• Latest Insights on Adenovirus Structure and Assembly

  2012cited by this paper
• Complete Regression of Metastatic Renal Cell Carcinoma by Multiple Injections of Engineered Mesenchymal Stem Cells Expressing Dodecameric TRAIL and HSV-TK

  2012cited by this paper
• Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles

  2012cited by this paper
• Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model.

  2012cited by this paper
• Selected medical conditions and risk of pancreatic cancer

  2012cited by this paper
• c-Met in pancreatic cancer stem cells: therapeutic implications.

  2012cited by this paper
• Immunosuppressive properties of mesenchymal stem cells: advances and applications.

  2012cited by this paper
• Integrin targeted oncolytic adenoviruses Ad5‐D24‐RGD and Ad5‐RGD‐D24‐GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

  2012cited by this paper
• Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4).

  2012cited by this paper
• Effects of capsid‐modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer

  2012cited by this paper
• Reversal of Multidrug Resistance by Gefitinib Via RAF1/ERK Pathway in Pancreatic Cancer Cell Line

  2012cited by this paper
• The Role of Chronic Inflammation: Chronic Pancreatitis as a Risk Factor of Pancreatic Cancer

  2012cited by this paper
• Potent growth-inhibitory effect of TRAIL therapy mediated by double-regulated oncolytic adenovirus on osteosarcoma

  2012cited by this paper
• Formation and regulation of the cancer stem cell niche

  2012cited by this paper
• Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents.

  2012cited by this paper
• A Specific Subpopulation of Mesenchymal Stromal Cell Carriers Overrides Melanoma Resistance to an Oncolytic Adenovirus

  2012cited by this paper
• The pathobiological impact of cigarette smoke on pancreatic cancer development (review).

  2012cited by this paper
• Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.

  2012cited by this paper
• Mining the Adenovirus Virome for Oncolytics Against Multiple Solid Tumor Types

  2011cited by this paper
• Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus.

  2011cited by this paper
• Impact of the coxsackievirus and adenovirus receptor on the adenoma–carcinoma sequence of colon cancer

  2011cited by this paper
• Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.

  2011cited by this paper
• A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.

  2011cited by this paper
• Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene

  2011cited by this paper
• Mesenchymal stem cells: a new promise in anticancer therapy.

  2011cited by this paper
• The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses

  2011cited by this paper
• c-Met is a marker of pancreatic cancer stem cells and therapeutic target.

  2011cited by this paper
• Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus

  2011cited by this paper
• Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors

  2011cited by this paper
• An oncolytic adenovirus defective in pRb-binding (dl922–947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine

  2011cited by this paper
• Adenovirus E1A Directly Targets the E2F/DP-1 Complex

  2011cited by this paper
• A short-term in vivo model for giant cell tumor of bone

  2011cited by this paper
• A New Generation of Serotype Chimeric Infectivity-Enhanced Conditionally Replicative Adenovirals: The Safety Profile of Ad5/3-Δ24 in Advance of a Phase I Clinical Trial in Ovarian Cancer Patients

  2011cited by this paper
• The cancer stem cell: premises, promises and challenges

  2011cited by this paper
• Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells

  2010cited by this paper
• Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors

  2010cited by this paper
• Improved Potency and Selectivity of an Oncolytic E1ACR2 and E1B19K Deleted Adenoviral Mutant in Prostate and Pancreatic Cancers

  2010cited by this paper
• Substitution of Adenovirus Serotype 3 Hexon onto a Serotype 5 Oncolytic Adenovirus Reduces Factor X Binding, Decreases Liver Tropism, and Improves Antitumor Efficacy

  2010cited by this paper
• The therapeutic promise of the cancer stem cell concept.

  2010cited by this paper
• Investigation of bone allografts representing different steps of the bone bank procedure using the CAM-model.

  2010cited by this paper
• Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells

  2010cited by this paper
• Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo

  2009cited by this paper
• New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster

  2009cited by this paper
• Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model

  2009cited by this paper
• Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

  2009cited by this paper
• Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity

  2009cited by this paper
• Transgene expression by oncolytic adenoviruses is modulated by E1B19K deletion in a cell type-dependent manner.

  2009cited by this paper
• "Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.

  2009cited by this paper
• Cancer Stem Cells in Solid Tumors

  2009cited by this paper
• Oncolytic adenoviruses targeted to cancer stem cells

  2009cited by this paper
• Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo

  2009cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Tumor Necrosis Factor‐Related Apoptosis‐Inducing Ligand Promotes Migration of Human Bone Marrow Multipotent Stromal Cells

  2008cited by this paper
• Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma

  2008cited by this paper
• Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

  2008cited by this paper
• Mesenchymal stem cells in health and disease

  2008cited by this paper
• Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus.

  2008cited by this paper
• Oncolytic virotherapy.

  2008cited by this paper
• Adenoviruses in Immunocompromised Hosts

  2008cited by this paper
• Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

  2007cited by this paper
• Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.

  2007cited by this paper
• Cancer Stem Cells

  2007cited by this paper

• No citing papers are available for this paper.